Foghorn Therapeutics Cash Flow Statement 2019-2024 | FHTX

Fifteen years of historical annual cash flow statements for Foghorn Therapeutics (FHTX).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022202120202019
$-98.43$-108.88$-101.32$-68.80$-51.13
$0.80$2.03$3.41$1.33$0.69
$21.40$18.92$14.22$7.49$2.90
$22.20$20.95$17.63$8.81$3.60
$0$0$0$0$0
$0$0$0$0$0
$0.85$1.61$0.14$0.47$1.21
$-40.93$278$30.65$25.04$-2.15
$-41.88$282$33.44$28.70$1.20
$-118.11$194$-50.25$-31.29$-46.34
$-1.22$-1.21$-3.31$-15.93$-0.96
$0$0$0$0$0
$0$0$0$0$0
$-73.90$-409.35$-99.98$-92.98$0
$220$166$139$0$0
$146$-243.11$39.49$-92.98$0
$0$0$0$0$0
$144$-244.32$36.17$-108.91$-0.96
$0$0$0$0$0
$0$0$-21.21$-15.53$0
$0$0$-21.21$-15.53$0
$1.78$1.76$1.42$1.22$0.69
$1.78$1.76$1.42$91.08$15.99
$0$0$0$0$0
$0$0$42.21$142$7.98
$1.78$1.76$22.42$217$23.97
$28.12$-48.95$8.34$77.27$-23.33
$16.19$14.34$8.38$2.96$1.69
$0$0$0$0$0